1st Edition

The Delivery of Regenerative Medicines and Their Impact on Healthcare

Edited By Catherine Prescott, Dame Julia Polak Copyright 2011
416 Pages 17 B/W Illustrations
by CRC Press

416 Pages 17 B/W Illustrations
by CRC Press

400 Pages
by CRC Press

Now that prohibitions against stem cell research are relaxing, it is time for the field to move forward with the advances that promise to eliminate so much human suffering. However, it would be naïve to ignore the fact that regenerative medicines pose a whole new set of challenges to an industry sector that for decades has geared itself to the development and delivery of traditional... Read more

Introduction
What Is Regenerative Medicine? J. Polak

Finance
A New Political-Financial Paradigm, R. Klein and A. Trounson
Investment Models 4. Public Funding in Australia, G. Macdonald
Capitalising On A 50-Year Legacy, A. Lyall
Investing in Regenerative Medicine: What Drives the Private Investor? C. Prescott
Public Investment Models: Coming Out of the Closet And Going Public! R. Benjamin

Business Models
Cell-Based Products: Allogenic, P. Kemp
Autologous Cell Based Products: Fulfilling the Promise of Cell Therapy, E. Bravo and M. Blanco-Molina
Business Models for Cord Blood, S. Watt
Changing the Game of Drug Discovery, J. Walker
Discovery of Small Molecule Regenerative Drugs, Y. Choo
The Adoption of Therapeutic Stem Cell Technologies by Large Pharmaceutical Companies, A. Vertes
Role of Tools and Technologies Companies in the Successful Commercialization of Regenerative Medicine, J. Goswami
Key Considerations in Manufacturing of Cellular Therapies, R. Preti
State of the Global Regenerative Medicine Industry, L. Buckler, R. Margolin, and S. Haecker

Intellectual Property
Regenerating Ip: Europe After Warf, J. Hitchcock and D. Crease
Protecting Regenerative Medicine Intellectual Propery in the Use: Problems and Strategies, D. Resnick, R. Eisenstein, and J. McWilliams
Impact of Indian Policies and Laws on Regenerative Medicine Patent Applications, P. Ganguli

The Regulatory Landscape
A CATalyst for Change: Regulating Regenerative Medicines in Europe, C. Bravery
The US Regulatory Reimbursement, Political Environment and Strategies for Reform, M. Werner

Reimbursement
The Fourth Hurdle: Reimbursement Strategies for Regenerative Medicine, F. Meurgey and Micheline
Cellular Therapies and Regenerative Medicine: Preparing for Reimbursement in the United States, E. Faulkner
The Adoption and Evaluation of Regenerative Medicine and the NHS, M. Parton

Insurance
If You Build It Will They Insure It? M. Clark

Biography

Catherine Prescott, Dame Julia Polak